{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:08:02Z","timestamp":1751515682325,"version":"3.41.0"},"reference-count":69,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128037249"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/b978-0-12-803724-9.00009-0","type":"book-chapter","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T21:09:10Z","timestamp":1520456950000},"page":"175-186","source":"Crossref","is-referenced-by-count":0,"title":["Adenosine Receptors and Memory Disorders"],"prefix":"10.1016","author":[{"given":"Alexandre","family":"de Mendonca","sequence":"first","affiliation":[]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[]},{"given":"Jonathan D.","family":"Geiger","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","article-title":"Size and burden of mental disorders in Europe\u2014a critical review and appraisal of 27 studies","volume":"15","author":"Wittchen","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14789450.5.2.207","article-title":"Biochemistry of Tau in Alzheimer\u2019s disease and related neurological disorders","volume":"5","author":"Sergeant","year":"2008","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib6","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nan.12200","article-title":"Invited review: Animal models of tauopathies and their implications for research\/translation into the clinic","volume":"41","author":"Dujardin","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0197-4580(97)80306-5","article-title":"Modeling the relation between neurofibrillary tangles and intellectual status","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/B978-0-12-803724-9.00009-0_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-4580(99)00063-9","article-title":"Memory and mental status correlates of modified Braak staging","volume":"20","author":"Grober","year":"1999","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1471-4159.1995.65041431.x","article-title":"Processing of the beta-amyloid precursor protein and its regulation in Alzheimer\u2019s disease","volume":"65","author":"Checler","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00023.2009","article-title":"Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process","volume":"90","author":"De Strooper","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","article-title":"The secretases: enzymes with therapeutic potential in Alzheimer disease","volume":"6","author":"De Strooper","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2013.10.037","article-title":"SnapShot: genetics of Alzheimer\u2019s disease","volume":"155","author":"Guerreiro","year":"2013","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib19","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1096\/fj.08-123877","article-title":"Accumulation of tau induced in neurites by microglial proinflammatory mediators","volume":"23","author":"Gorlovoy","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib21","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-\u03b242 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-003-3269-3","article-title":"Caffeine as a psychomotor stimulant: mechanism of action","volume":"61","author":"Fisone","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00213-004-2104-3","article-title":"Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine","volume":"179","author":"Haskell","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00845371","article-title":"Caffeine and human behavior: arousal, anxiety, and performance effects","volume":"5","author":"Sawyer","year":"1982","journal-title":"J Behav Med"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002130000506","article-title":"Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers","volume":"152","author":"Smit","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0278-2626(03)00206-9","article-title":"Caffeine, fatigue, and cognition","volume":"53","author":"Lorist","year":"2003","journal-title":"Brain Cogn"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nn.3623","article-title":"Post-study caffeine administration enhances memory consolidation in humans","volume":"17","author":"Borota","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.40.11.1698","article-title":"A case-control study of Alzheimer\u2019s disease in Australia","volume":"40","author":"Broe","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","article-title":"Does caffeine intake protect from Alzheimer\u2019s disease?","volume":"9","author":"Maia","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","article-title":"The neuroprotective effects of caffeine: a prospective population study (the Three City Study)","volume":"69","author":"Ritchie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12603-014-0563-8","article-title":"Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review","volume":"19","author":"Panza","year":"2015","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-2010-101428","article-title":"Coffee intake in midlife and risk of dementia and its neuropathologic correlates","volume":"23","author":"Gelber","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib35","doi-asserted-by":"crossref","first-page":"617420","DOI":"10.4061\/2011\/617420","article-title":"Increased cerebrospinal fluid production as a possible mechanism underlying caffeine\u2019s protective effect against Alzheimer\u2019s disease","volume":"2011","author":"Wostyn","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1389200211209050667","article-title":"Measurement of CYP1A2 activity: a focus on caffeine as a probe","volume":"13","author":"Perera","year":"2012","journal-title":"Curr Drug Metab"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-803724-9.00009-0_bib37","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"20","author":"Costa","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib38","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/aje\/kwr229","article-title":"EURALS Group. Coffee and amyotrophic lateral sclerosis: a possible preventive role","volume":"174","author":"Beghi","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2013.05.013","article-title":"Association between caffeine intake and age at onset in Huntington\u2019s disease","volume":"58","author":"Simonin","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-803724-9.00009-0_bib40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3233\/JAD-2010-01420","article-title":"Therapeutic opportunities for caffeine in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"20","author":"de Mendon\u00e7a","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1534\/genetics.110.120436","article-title":"Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of \u03b2-amyloid peptide toxicity","volume":"186","author":"Dostal","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib42","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.4777-09.2010","article-title":"Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson\u2019s disease through an NRF2-dependent mechanism","volume":"30","author":"Trinh","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer\u2019s mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer\u2019s disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib45","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2010.07.007","article-title":"Caffeine protects against oxidative stress and Alzheimer\u2019s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet","volume":"49","author":"Prasanthi","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JAD-142223","article-title":"Caffeine, Through adenosine A3 receptor-mediated actions, suppresses amyloid-\u03b2 protein precursor internalization and amyloid-\u03b2 generation","volume":"47","author":"Li","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib47","doi-asserted-by":"crossref","unstructured":"Soliman ML, Geiger JD, Chen X. Caffeine blocks HIV-1 Tat-induced amyloid beta production and tau phosphorylation. J Neuroimmune Pharmacol. 2016 (in press).","DOI":"10.1007\/s11481-016-9707-4"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib48","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","article-title":"Beneficial effects of caffeine in a transgenic model of Alzheimer\u2019s disease-like tau pathology","volume":"35","author":"Laurent","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib49","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","article-title":"Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum","volume":"107","author":"Chen","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-5-12","article-title":"Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer\u2019s disease","volume":"5","author":"Chen","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib51","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.3233\/JAD-2010-1376","article-title":"Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"20","author":"Chen","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib52","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbamem.2010.12.017","article-title":"Recent developments in adenosine receptor ligands and their potential as novel drugs","volume":"1808","author":"M\u00fcller","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00001756-199507310-00029","article-title":"Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat","volume":"6","author":"Cunha","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib54","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1152\/jn.1999.82.6.3196","article-title":"Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats","volume":"82","author":"Lopes","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib55","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/jn.00896.2002","article-title":"Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats","volume":"90","author":"Rebola","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib56","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/npp.2011.64","article-title":"Enhancement of LTP in aged rats is dependent on endogenous BDNF","volume":"36","author":"Di\u00f3genes","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib57","doi-asserted-by":"crossref","first-page":"31493","DOI":"10.1038\/srep31493","article-title":"The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function","volume":"6","author":"Batalha","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib58","doi-asserted-by":"crossref","unstructured":"Barros-Barbosa AR, Ferreirinha F, Oliveira A, et al. Adenosine A(2A), receptor and ecto-5\u2019-nucleotidase\/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE). Purinergic Signal. 2016;12(4):719-734.","DOI":"10.1007\/s11302-016-9535-2"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib59","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2174\/156802611795347591","article-title":"Adenosine and related drugs in brain diseases: present and future in clinical trials","volume":"11","author":"Lopes","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","article-title":"Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory","volume":"18","author":"Orr","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib63","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1038\/ncomms11915","article-title":"Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A2A receptors","volume":"7","author":"Viana da Silva","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib64","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.expneurol.2011.01.018","article-title":"In vitro modelling of Alzheimer\u2019s disease: degeneration and cell death induced by viral delivery of amyloid and tau","volume":"229","author":"Stoppelkamp","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib66","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","article-title":"Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity","volume":"138","author":"Dall\u2019Igna","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib67","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.expneurol.2007.11.013","article-title":"Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801","volume":"210","author":"Cunha","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib68","doi-asserted-by":"crossref","first-page":"e88508","DOI":"10.1371\/journal.pone.0088508","article-title":"Hydrogen sulfide inhibits A2A adenosine receptor agonist induced \u03b2-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway","volume":"9","author":"Nagpure","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-803724-9.00009-0_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mp.2015.115","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol Psychiatry"}],"container-title":["Adenosine Receptors in Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128037249000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128037249000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:19:50Z","timestamp":1751465990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128037249000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128037249"],"references-count":69,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-803724-9.00009-0","relation":{},"subject":[],"published":{"date-parts":[[2017]]}}}